ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,783Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 56

$801K Total Retail Price of All Prescriptions

Rank: 12 out of 56

1,112 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,230 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 44%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SYNTHROID 1,257 986 1 1
LEVOTHYROXINE SODIUM 804 626 2 4
METFORMIN HCL 757 603 3 2
LOSARTAN POTASSIUM 541 447 4 7
AMLODIPINE BESYLATE 521 470 5 11
SIMVASTATIN 457 398 6 3
HUMALOG MIX 75-25 437 335 10 7 15
GLIMEPIRIDE 375 328 8 5
PRAVASTATIN SODIUM 304 239 9 20
ATORVASTATIN CALCIUM 295 214 10 13
LOSARTAN-HYDROCHLOROTHIAZIDE 290 247 11 8
GABAPENTIN 249 188 12 9
CRESTOR 243 204 13 19
METFORMIN HCL ER 230 188 14 23
LANTUS 209 173 15 12
INSULIN SYRINGE 183 144 16 26
JANUVIA 150 141 17 22
RAMIPRIL 139 116 18 30
LEVOXYL 139 124 18 6
ENALAPRIL MALEATE 133 104 20 10
VERAPAMIL ER 121 114 21 54
METOPROLOL SUCCINATE 115 104 22 32
HUMALOG 111 56 23 24
SERTRALINE HCL 107 87 24 87
OMEPRAZOLE 107 94 24 25
ZOLPIDEM TARTRATE 102 66 26 57
JANUMET 98 82 27 14
CARVEDILOL 94 76 28 34
HUMULIN N 88 65 29 27
FUROSEMIDE 84 67 30 46
HYDROCHLOROTHIAZIDE 83 66 31 33
DIOVAN 81 80 32 50
HUMALOG MIX 50-50 78 57 33 44
ETODOLAC 77 50 34 110
LISINOPRIL 76 68 35 29
ONGLYZA 71 64 36 43
RANITIDINE HCL 66 63 37 31
LOVAZA 63 51 38 84
EVISTA 63 48 38 36
NOVOLOG MIX 70-30 63 56 38 62
ATENOLOL 62 53 41 16
LYRICA 61 50 42 87
IRBESARTAN 58 53 43 39
BENICAR HCT 58 58 43 132
PLAVIX 56 45 45 51
DIOVAN HCT 56 49 45 47
LEVEMIR 56 37 45 65
IRBESARTAN-HYDROCHLOROTHIAZIDE 53 52 48 86
NOVOLOG 50 43 49 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.